PFS was similar between the subgroups and significantly prolonged in patients treated with pemetrexed than placebo ( median PFS : East Asian , 4.4 versus 1.6 months , HR = 0.42 , p < 0.001 ; non-East Asian , 4.5 versus 2.8 months , HR = 0.45 , p < 0.001 ) .
